Company intelligence / Profile preview

Oatmeal Health

USA

Ownership: Private
Development stage: Other

Overview

Oatmeal Health’s AI-driven ICARE platform is used for high-accuracy identification of high-risk patients for lung cancer screening, increasing early detection and improving compliance at Federally Qualified Health Centers (FQHCs). Their platform is commercial, with proven increases in screening rates, and validates outcomes like ninefold staff efficiency gains and 91% patient engagement with low-dose CT scheduling, but they do not directly sponsor clinical trials[1][2].

Therapeutic areas: Oncology
Modalities: DeviceSoftware as a ServiceArtificial Intelligence
Industry: Digital Health Medical Devices

Partnerships

El Rio HealthStigler Health & Wellness CenterLowell Community Health CenterLung Cancer Research FoundationIllinois Primary Healthcare AssociationThe CHC AllianceHealth Gorilla

Beyond the preview

Go deeper on Oatmeal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oatmeal Health.

Explore the full profile